CIK 0001833769
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Hyperfine, Inc.
Sign in to watch- Ticker
- HYPR
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 866-796-6767
- Business address
- 351 NEW WHITFIELD STREET, GUILFORD, CT, 06437
- Former names
- HealthCor Catalio Acquisition Corp.
- 4 Open-market sale Chief Operating Officer sold 2,785 shares at $2.26 ($6,294)
- 4 Open-market sale CMO and Chief Strategy Officer sold 1,729 shares at $2.26 ($3,908)
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CMO and Chief Strategy Officer sold 1,735 shares at $1.25 ($2,169)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CMO and Chief Strategy Officer sold 4,635 shares at $1.39 ($6,443)
- 4 Open-market sale Chief Financial Officer sold 5,613 shares at $1.39 ($7,802)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 250,000 shares at an average $5.44 ($1,359,255)
Page 3 of 8 · 144 filings